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INTRODUCTION 
A fistula in ano is a granulating track between the anorectum and  perineum. 
(Fistula literally translated from Latin means a pipe or reed). 
Many fistulas are low lying, consisting of single straight track from skin to 
anal canal, traversing the lower fibers of internal anal sphincter. 
Majority of such fistula can therefore be managed by simple laying open of 
the track(fistulotomy) or excision of the tract (fistulectomy)with good prospect of 
cure and no impairment of continence. 
A fistula may consist of primary and secondary tracks. Some of these tracks 
occlude and a sinus remains. Laying open of such fistulas causes serious and often 
impaired continence.Unless all the secondary tracks are attended there is a risk of 
recurrent sepsis and fistulation. 
Possibly in no other field of anorectal surgeryis appropriate treatment so 
critical (phillips and luniss1996 ). 
The potential for incurring life long morbidity may be greater than any other 
sphere of large bowel surgery. 
 
 
 
 
OBJECTIVES OF STUDY 
   A PROSPECTIVE study of fistulotomy vs fistulectomy in management of  
patients with low Anal fistulae presenting in general surgery OPD at chengalpattu 
government medical college hospital. 
To evaluate the outcome of patients treated with fistulotomy compared to 
fistulectomy in anal fistula  in terms of  
 postoperative pain ,  
 bleeding, 
 infection , 
 wound healing. 
 
  
MATERIALS AND METHODS 
 This prospective study was carried out in our institution over a period of 1 
year from 1
st
november 2013 to 30
th
 September 2014. All patients attending our 
institution found to have low anal fistula by clinical  examination and 
investigations are included in the study.  
Data’s regarding name, age, inpatient number, gender, relevant history, 
physical status, investigations such as hemoglobin%, complete blood count  TC, 
DC, blood sugar, urea, creatinine, electrolytes, serum proteins, Blood grouping and 
Rh typing, Chest radiograph,procedure done (fistulotomy /fistulectomy), post-
operative complications  were tabulated and recorded in the prescribed format. 
Post-operative complication given emphasis were 
1. Bleeding 
2.  Pain 
3. Wound healing 
4. Infection 
5. Incontinence (feces/flatus) 
  
Cases are selected by following Inclusion and exclusion criteria; 
Inclusion criteria; 
 All patients with low anal fistula identified by clinical examination and 
investigations 
 Age >13yrs and <70yrs. 
 
Exclusion criteria; 
 Pediatric age <12yrs 
 Pregnant women 
 Lactating mothers 
 Patients with high anal fistula identified by  clinical examination and 
investigations. 
 Patients with  crohn`s disease/HIV/TB 
  
REVIEW OF LITERATURE 
HISTORICAL CONSIDERATIONS 
1. Treatment of fistula in ano was described by Hippocrates in 460 BC. 
2. Adams (1849) in his translation for Sydenham society describes the use of 
stalk of fresh garlic as a means of examining the track of a fistula. these 
fistula were  thought to be exacerbated by local trauma , particularly by 
horse riding and rowing. 
3. Hippocrates was remarkably advanced in his treatment philosophy.Early 
drainage was advised .The use of seton and fistulotomy is also described. 
4. Hippocrates  advised the use of strip of linen smeared with caustic juice of 
euphorbiato act as seton , an approach later adopted by ancient physicians 
and named Kshara sutra thread. 
5. Celsus advised using a probe :put a probe into the fistula to see where it goes 
and how deeply it reaches, also whether it is moist or dry. 
6. In the middle ages fistulotomy was widely practised and was described by 
John of Ardenne. 
7. Percival Pott (1765) advocated laying open of anal fistulasand emphasized 
the importance of packing of wounds.  
 
8. In Paris Felix treated an anal fistula in Louis XIV, an acheivement that 
provided him an honorarium that he was able to establish five chairs in 
surgery.  
9. Frederick Salmon , founder of St.Mark's hospital over 150 years ago , 
established the principles of treating fistula in ano which are widely 
practised now . 
 
 
JOHN OF ARDENE 
 
  
EMBRYOLOGY 
ANAL CANAL 
            Anal canal is formed partly from endoderm of primitive rectum (Hindgut) 
and partly from ectoderm of anal pit or proctadeum. 
          In the fifth week, the embryonic cloaca is an endodermal sac receiving the 
hindgut dorsally and the allantoic stalk ventrally.  
            The cloaca (Fig. A, B) is separated from the outside by a thin cloacal 
membrane (proctodeum), which occupies the embryo's ventral surface between the 
tail and the body stalk.  
           During the sixth week, a septum of mesoderm divides the cloaca into a 
ventral urogenital sinus and a dorsal rectum (Fig. C) . This mesodermic septum 
fuses with the cloacal membrane in the seventh week to form the perineal body.  
               Externally, the anal membrane becomes slightly depressed, forming the 
anal dimple.  
               
  
By the eighth week, the anal membrane ruptures, leaving no trace of itself (Fig. D). 
 
 
          The pectinate line in the adult is often considered to be at the level of the 
anal membrane, but little evidence exists to either support or contradict this view. 
            Whatever the exact line of demarcation, the rectum and the upper anal canal 
are endodermal and are supplied by the inferior mesenteric artery, 
while the lower anal canal is ectodermal and is supplied by branches of the internal 
iliac artery. 
             On either side of the anal membrane, the somatic mesoderm forms a pair of 
anal tubercles.  
   These tubercles fuse dorsally into a horseshoe-shaped structure. By the tenth 
week, the ventral tips of the horseshoe fuse with the perineal body. 
  Striated muscle in this horseshoe-shaped structure will later become the 
superficial portion of the external anal sphincter.  
The anal sphincter will form at the normal location even if the rectum should end 
blindly or should open at another site. 
 
 
 
  
 ANATOMY OF ANAL CANAL 
 
         Alimentary tract terminates at the anus, which provides continence of flatus 
and feces. It is useful to consider the anus and surrounding structures as a single 
unit, the anorectum . 
 
       The anorectum includes the perianal skin, the anal canal, the anal sphincters, 
and the distal rectum. 
 
 
         The three main anatomic points of reference are the anal verge, the dentate 
line, and the anorectal ring. The distal external boundary of the anal canal is the 
anal verge, which is also the junction between the anal and perianal skin. Anal 
epithelium (anoderm) is devoid of the hair follicles, sebaceous glands, and apocrine 
glands that are present in the perianal skin. 
 
             The cephalad border of the anal canal is a true mucocutaneous junction, the 
dentate line. This union of the embryonic ectoderm with the endodermal gut resides 
approximately 1.0–1.5 cm above the anal verge. 
             
 
  In a transitional zone of 6–12 mm in length, the columnar epithelium of the 
rectum changes to cuboidal epithelium which joins the squamous epithelium at the 
dentate line. 
 
The upper border of the anal sphincteric complex is the anorectal ring. It 
may be palpated by digital examination about 1.0–1.5 cm above the dentate line. 
 
Anatomists consider the anal canal to begin at the dentate line and end at the 
anal verge. However, most surgeons consider the anal canal to start at the anorectal 
ring and terminate at the anal verge.  
 
  Between each two columns at the dentate line is a small pocket termed an 
anal crypt. 
 
Small, rudimentary anal glands open into some, but not all, of these anal 
crypts.  
 
The glands may extend through the internal sphincter as far as the 
intersphincteric plane, but they do not extend into the external sphincter. 
 Below the dentate line, cutaneous sensations of heat, cold, touch, and pain 
are conveyed by afferent fibers in the inferior rectal nerves. 
 
  Cephalad to the dentate line, poorly defined dull sensations, elicited when 
the mucosa is pinched or internal hemorrhoids are ligated, are probably carried by 
parasympathetic fibers. 
  
 ARTERIAL SUPPLY 
 
 
The superior rectal artery, the terminal branch of the inferior mesenteric 
artery, descends to the upper rectum where it divides into lateral branches. 
Subsequent smaller divisions penetrate the rectal wall.  
The middle rectal arteries arise from the internal iliac arteries and supply the 
distal rectum and upper anal canal.  
The inferior rectal arteries, branches from the internal pudendal arteries, 
cross the ischiorectal fossae to supply the anal sphincters 
 VENOUS DRAINAGE 
 The anal veins are distributed in a similar fashion to the arterial supply. The 
upper anal canal is drained by the portomesenteric venous system.  The  lower half 
of the anal canal drain into  the subcutaneous perianal plexus of veins: they 
eventually join the internal iliac vein on each side. 
 
NERVE SUPPLY 
The anorectum receives both sympathetic and parasympathetic nerves. The 
sympathetic nerves originate from thoracolumbar segments, and unite below the 
inferior mesenteric artery to form the inferior mesenteric plexus. These fibers then 
descend to the superior hypogastric plexus located just inferior to the aortic 
bifurcation. These purely sympathetic fibers bifurcate and descend as the 
hypogastric nerves.  
Parasympathetic fibers (the nervi erigentes) join the hypogastric nerves 
anterolateral to the rectum to form the inferior hypogastric plexuses. 
 Mixed fibers from the plexuses innervate the prostate, rectum, bladder, 
penis, and internal anal sphincter.  
These autonomic plexuses of the pelvic nerves run around the lateral aspect 
of the pelvic rim to enter the prostate and seminal vesicles anteriorly.  
 The sympathetic innervation of the internal sphincter is motor, while the 
parasympathetic innervation is inhibitory.  
Injury to the pelvic autonomic nerves during pelvic surgery may result in 
bladder dysfunction, impotence, or both. 
  The nerves of the external sphincter are via the pudendal nerve around the 
ischial spine at Alcock's canal.  
 
 
  
LYMPHATIC DRAINAGE 
 Lymph from the upper half of the anal canal flows upwards to drain into the 
postrectal lymph nodes and from there goes to the para-aortic nodes via the inferior 
mesenteric chain.  
 
Lymph from the lower half of the anal canal drains on each side first into the 
superficial and then into the deep inguinal group of lymph glands. 
 
  However, if the normal flow is blocked, e.g. by tumour, the lymph can be 
diverted into the alternative route 
 
  
THE ANORECTAL RING 
The anorectal ring marks the junction between the rectum and the anal canal. 
It is formed by the joining of the puborectalis muscle , the deep external sphincter, 
conjoined longitudinal muscle and the highest part of the internal sphincter. 
  The anorectal ring can be clearly felt digitally, especially on its posterior and 
lateral aspects. 
  The puborectalis muscle part of the funnel-shaped muscular pelvic 
diaphragm, maintains the angle between the anal canal and rectum and hence is an 
important component in the continence mechanism . 
  The muscle derives its nerve supply from the sacral somatic nerves, and is 
functionally indistinct from the external anal sphincter.  
 It gives off fibres that contribute to the longitudinal muscle layer  
 
 
MUSCLES OF THE ANAL CANAL 
External Sphincter : 
The external sphincter forms the bulk of the anal sphincter complex and, 
although traditionally it has been subdivided into deep, superficial and 
subcutaneous portions, it is a single muscle (Goligher), which is variably divided 
by lateral extensions from the longitudinal muscle layer. 
 
  Some of its fibres are attached posteriorly to the coccyx, whereas anteriorly 
they fuse with the perineal muscles.  
 
Being a somatic voluntary muscle, the external sphincter is red in colour and 
is innervated by the pudendal nerve 
 
Internal Sphincter : 
The internal sphincter is the thickened (2–5 mm) distal continuation of the 
circular muscle coat of the rectum, which has developed special properties and 
which is in a tonic state of contraction.  
 
 
This involuntary muscle commences where the rectum passes through the 
pelvic diaphragm and ends above the anal orifice, its lower border palpable at the 
intersphincteric groove, below which lie the most medial fibres of the subcutaneous 
external sphincter, and separated from it by the anal intermuscular septum. 
  
 
When exposed during life, it is pearly-white in colour and its 
circumferentially placed fibres can be seen clearly. 
 
  Although innervated by the autonomic nervous system, it receives intrinsic 
non-adrenergic and non-cholinergic (NANC) f ibres, stimulation of which causes 
release of the neurotransmitter nitric oxide, which induces internal sphincter 
relaxation. 
 
Longitudinal Muscle : 
The longitudinal muscle is a direct continuation of the smooth muscle of the 
outer muscle coat of the rectum, augmented in its upper part by striated muscle 
fibres originating from the medial components of the pelvic floor. 
  Most of the muscle continues caudally before splitting into multiple terminal 
septa that surround the muscle bundles of the subcutaneous portion of the external 
sphincter to insert into the skin of the lowermost part of the anal canal and adjacent 
perianal skin.  
 Milligan and Morgan named the most medial of these septa, passing around 
the inferior border of the internal sphincter, the ‘anal intermuscular septum’. 
 
 As well as providing a supportive mesh for the anal canal and other 
muscular components, its ramifications provide potential pathways for the spread 
of infection. 
 
During defaecation, its contraction widens the anal lumen, flattens the anal 
cushions, shortens the anal canal and everts the anal margin; subsequent relaxation 
allows the anal cushions to distend and thus contribute to an airtight seal 
 
Inter Sphincteric Plane : 
Between the external sphincter muscle laterally and the longitudinal muscle 
medially exists a potential space, the intersphincteric plane. 
 
  This plane is important as it contains intersphincteric anal glands and is also 
a route for the spread of pus, which occurs along the extensions from the 
longitudinal muscle layer. 
  The plane can be opened up surgically to provide access for operations on 
the sphincter muscles 
 
 
 
  
 
 
 
ANORECTAL SPACES 
Six potential spaces around the rectum are recognized by Shafik. They are 
important because they may become sites of infection. 
 
  The fascial layers that bound these spaces help limit the spread both of 
infection and of neoplastic disease, although all are potentially confluent with one 
another. 
 
  
Subcutaneous space 
The subcutaneous space corresponds to the perianal space of Milligan and 
associates. It is bounded above by the lowest muscular loop of the external 
sphincter, below by the perianal skin, and medially by the epithelium of the anal 
verge.  
It is filled with fat and by fibers of the corrugator ani cutis. The 
subcutaneous space is in communication above with the central space and laterally 
with the ischioanal (ischiorectal) space. 
  Medially, the medial central septum separates it from the submucous space. 
The subcutaneous space is often considered to be a part of the ischioanal space. 
 
Central Space 
The central space is considered by Shafik to be the main perianal space; it is 
in communication with each of the others. 
 It surrounds the anal canal and is bounded by the termination of the 
longitudinal muscles above and the lowest muscular loop of the external sphincter 
below.           
Within it lie the tendon fibers of the longitudinal muscles. 
 
  
Intersphincteric Spaces 
The intersphincteric spaces are four upward extensions of the central space. 
They are the fascial planes between the longitudinal intersphincteric muscles that 
form the upper boundary of the central space.  
 
  These "spaces" are potential pathways of infection and are potential spaces 
only. 
 
 Ischioanal (Ischiorectal) Fossa 
  This bilaminar fascial layer, also called the rectovaginal or rectovesical 
septum, separates the rectum from the prostate and The ischioanal (ischiorectal) 
fossa is a pyramidal space on either side of the anal canal and lower rectum, 
posterior to the base of the urogenital diaphragm.  
 base is at the perianal skin; 
 medial wall is the external anal sphincter and levator;  
 lateral wall is the internal obturator fascia 
 apex is where the levator muscles join the obturator internus muscle. 
  
 The two spaces communicate posteriorly through the retrosphincteric space. 
The lower portion of the ischioanal (ischiorectal) space has been termed 
the perianal space by Milligan. 
 
 Laterally it communicates with the gluteal fat and the subcutaneous space. It 
is usually considered a part of the ischioanal fossa. 
 
Pelvirectal Spaces 
The pelvirectal spaces lie above the levators and are bounded superiorly by 
the pelvic peritoneum, laterally by the pubococcygeus muscle, and medially by the 
rectum.  
 
The spaces are filled with fibroadipose tissue. The fibrous elements of the 
tissue, known as the lateral ligaments of the rectum, connect the parietal pelvic 
fascia with the walls of the rectum and pelvis. 
 
These ligaments form a triangle, with its base on the side wall of the pelvis 
and the apex joining the rectum.  
 
The lateral ligaments conduct the middle rectal vessels and nerves. The 
lateral pelvirectal spaces on either side of the rectum communicate behind the 
rectum, in front of the sacrum, and above the levators.  
 
 
This communication is separated from the rectal wall by the fascia propria of 
the rectum and from the sacrum by a thickened parietal pelvic fascia called 
the fascia of Waldeyer. 
 
The middle sacral vessels lie within this fascia, which is often considered to 
be a separate space (the rectorectal or presacral space). 
 
The extraperitoneal anterior part of the rectum is covered with a bilaminar 
fascial layer (Denonvilliers' fascia) that extends from the anterior peritoneal 
reflection above to the perineal body below.  
 
Posterolaterally, this connective tissue septum is continuous with connective 
tissue of the sacrogenital or uterosacral folds and the lateral pillar of the rectum. 
This fascia forms a barrier to the spread of cancer or infection either 
anteriorly or posteriorly. 
  
Submucous Space 
The submucous space of Shafik  lies beneath the anal mucosa and the 
internal sphincter.  
 
It is the most distal portion of the submucosa of the digestive tract. While it 
is certainly a possible pathway for infection, it does not contribute to the 
longitudinal spread of cancer . 
 
A mucosal ligament described by Parks as connecting the anal mucosa and 
the internal sphincter would form the lower limit of the submucous space. The 
presence of such a ligament has not been confirmed by Shafik or by Goligher. 
 
Retrorectal Space 
The retrorectal space, according to Jackman  has the following boundaries: 
 Anterior: Fascia propria of the posterior rectal wall , 
 Posterior: Presacral fascia , 
 Lateral: Iliac vessels, ureters, lateral rectal ligaments, 
 Superior: Peritoneum,  
 Inferior: Retrosacral fascia 
   
THE ANAL GLANDS 
The Anal glands (which are not vestigial remnants of sexual scent glands) 
may be found in the submucosa and intersphincteric space , and normally number 
between 0 and 10 in an individual.  
 
They drain via ducts into the anal sinuses at the level of the dentate line. Not 
all sinuses have a duct draining into them and, occasionally, more than one gland 
can discharge into the same sinus. 
 
 Their function is unknown, although they secrete mucin (distinct from that 
secreted by the rectal epithelium), which perhaps lubricates the anal canal to ease 
defaecation.  
 
The importance of intersphincteric anal glands is that they are widely 
considered to be the potential source of anal sepsis, either acute, presenting as 
perianal, ischiorectal or even pelvic sepsis, or chronic, presenting as a 
cryptoglandular (non-specific) anal fistula. 
 Anal Gland 
  
  
AETIOLOGY AND PATHOGENESIS 
Anal gland theory : 
Most fistulas occur after drainage of a previous anorectal abscess, but not all 
abscess are complicated by fistula and not all patients with fistula give a history of 
a history of previous sepsis. 
 
Despite this observation , there is overwhelming evidence that majority of 
anal fistula are associated with sepsis in the intersphinceteric plane caused by an 
infected anal gland.(Thomson and Park) 
 
The Anal glands, eight or more in number and lie in the submucosa , internal 
sphincter and intermuscular plane, but they do not traverse the longitudinal muscle 
fibres or external anal sphincter anal sphincter since developmentally, they are 
visceral and not somatic structures.  
 
They are flask shaped and their ducts are lined by modified stratified 
transitional epithelium. 
 
The glands are most abundant posteriorly and in lower anal canal. There are 
two types of anal gland 
1.Submucosal 
2.Intermuscular. 
 
Ductal openings of anal inter muscular glandsare distributed equally around 
circumference of anal canal. Anal gland infection causes an abscess, in 
intersphincteric plane which either  rupture or resolve spontaneously.  
 
Spread of the infection is usually caudal towards the perineum along the 
fibroelastic septa,of perianal region. Less commonly sepsis spreads upwards in a 
high intersphincteric or supralevator abscess.Once abscess is drained or 
spontaneously discharge it forms a potential fistula. 
  If the track becomes epitheliased the fistula persists. 
 Pathogenesis 
  
 OTHER CAUSES 
Congenital fistulas : 
Intersphincteric , pelvic dermoid cyst if ruptured, Operations for congenital 
disorders-anal anastomosis after pull through for anorectal agenesis or 
Hirschprung's disesase. 
 
Pelvic sepsis : 
Causing a chronic supra levator abscess spreading caudally in intermuscular 
space resulting in high intersphincteric fistula or burst through levator ani leading 
to atypical ischiorectal abscess and extra sphincteric fistula. 
Usual causes includes appendicitis , salpingitis, Diverticulitis ,pelvic 
neoplasms.  
 
Perineal injuries : 
Blunt trauma , stab or blast  injury,impalement injury,  road traffic accident 
may result in high anorectal fistula. Coexistent urethral trauma should be 
considered.  
 
  
Anal disorders : 
1. Fissure in ano-a short superficial fistula running from base of fissure to 
hypertrophied anal papillae. 
Almost always in midline , representing 7% of all anorectal fistula  
 
2 . Hidradenitis -usually a superficial fistula -submucosal or subcutaneous due to 
obstructed and infected apocreine  gland. 
FOLLICULAR OCCLUSUM TETRAD-extreme condition causing multiple high 
anal fistula (pyoderma fistulans) 
 
3. Hemorrhoids 
Sepsis in thrombosed perianal hemorrhoids may result in subcutaneous or 
submucous fistula 
  
 4. Operations for anal disease : 
Classically after sclerotherapy for hemorrhoids, ocassionaly after closed 
hemorrhoidectomy or internal sphincterotomy 
 
Sexually transmitted diseases : 
AIDS, syphilis, lymhogranuloma venerum may cause perianal sepsis leading to 
fistulas. 
 
Inflammatory bowel diseases: 
1.Crohn's disease  
Typical features include recurrent abscess, fistulas, skin tags, ulcers, 
strictures,Multiple Extra sphincteric or high trans sphincteric Fistulas are common. 
 
2. Ulcerative colitis 
Fistula are less common than in Crohn's disease. 
 
  
Tuberculosis : 
Perianal fistulas are less common today than in early twentieth century. 
No specific clinical features, diagnosis established by tissue biopsy-epitheloid giant 
cells more reliable than AFB identification.  
Most cases are presumed to be of bovine origin. 
 
Actinomycosis : 
Indurated perineum with multiple sinuses. 
May cause Complications in an anal fistula. 
Lesions heal completely with antibiotic therapy. 
 
Malignancy : 
Fistula may be first presenting feature of anorectal tumour -cloacogenic 
adenocarcinoma , anal glandular malignancy. 
  
 CLASSIFICATION 
1 . Milligan and Morgan, 1934 -described the course of fistula in relation to 
external sphincter.Low fistulas open into anal canal at thr level of dentate 
linewhich could be submucous or subcutaneous or trans sphincteric  , all others 
were classified as high. 
 
2. Goligher , 1975 - recognised that some trans sphincteric fistulas entered below 
puborectalis into upper anal canal, while remainder were either supralevator or 
infralevator 
 
3. Thompson, 1962 -simple or complex fistula ; complex referring to high  fistulas 
or those involving at least 75% of circumference of anorectum.  
 
4. Steltzner , 1959 -classified them as intersphincteric , trans sphincteric or extra 
sphincteric 
 
5. Parks, 1976 -widely accepted ; includes supra sphincteric fistula and 
incorporates a description of secondary track /circumferential spread. 
 Parks Classification 
 
  
 
PARKS CLASSIFICATION 
Most widespread and useful classification of anal fistulae is that proposed by 
Parks, based on the centrality of intersphincteric anal gland sepsis (the internal 
opening is usually at the dentate line), which results in a primary track whose 
relation to the external sphincter defines the type of fistula and which influences 
management. 
 
1. Intersphincteric fistulas  
Intersphincteric fistulae (45 per cent) do not cross the external sphincter (bar, 
for the purist, the most medial subcutaneous fibres running below the distal border 
of the internal sphincter). 
 
Most commonly they run directly from the internal to the external openings 
across the distal internal sphincter, but may extend proximally in the 
intersphincteric plane to end blindly with or without an abscess, or enter the rectum 
at a second internal opening 
  
Subdivided into 7 categories - 
 Simple track passes through the internal sphincter to site of infected anal 
gland, hence downwards in the intersphincteric  plane to perianal region. 
 Simple with closed external opening and abscess. 
  
 High blind track a secondary track runs up in the inter sphincteric plane to 
the pararectal region without opening into rectum or  an abscess 
 High track entering rectum 
 High track with a supralevator abscess 
 High blind track with supralevator abscess without perianal opening 
 High track entering rectum without a perianal opening 
 
2.Trans sphincteric fistulas : 
Trans-sphincteric fistulae (40 per cent) have a primary track that crosses 
both internal and external sphincters (the latter at a variable level) and which then 
passes through the ischiorectal fossa to reach the skin of the buttock.  
 
The primary track may have secondary tracks arising from it, which often 
reach the roof of the ischiorectal fossa, which may rarely pass through the levators 
to reach the pelvis and which may spread circumferentially (horseshoe). 
Circumferential spread of sepsis may occur in the intersphincteric and pararectal 
planes, as well as in the ischiorectal plane 
 
 Subdivisions of Trans sphincteric fistulas 
 Simple- not a homogeneous entity, fistulous track may enter the anal canal at 
a high or low level. Accordingly termed as low /mid/high trans sphincteric.  
 Without perianal opening and recurrent abscess 
 High blind track 
 High blind track with supralevator abscess 
 3.Suprasphincteric fistulas 
Suprasphincteric fistulae are very rare, are thought by some to be iatrogenic 
and are difficult to distinguish from high-level trans-sphincteric tracks (for which, 
fortunately, management strategies are similar).  
 
  
May be subdivided into  
 Simple Suprasphincteric 
 With supralevator abscess. 
4.Extra sphincteric fistulas : 
Extrasphincteric fistulae run without specific relation to the sphincters and 
usually result from pelvic disease or trauma. 
 
 
Most due to over enthusiastic drainage of ischiorectal abscess when rectal 
waes inadvertently damaged or due to drainage of supralevator abscess secondary 
to transsphincteric fistula into rectum. 
CLINICAL PRESENTATION 
Patients usually complain of intermittent purulent discharge (which may be 
bloody) and pain (which increases until temporary relief occurs when the pus 
discharges).  
There is often, but not invariably, a previous episode of acute anorectal 
sepsis that settled (incompletely) spontaneously or with antibiotics, or which was 
surgically drained.  
 
  
The passage of flatus or faeces through the external opening is suggestive of 
a rectal rather than an anal internal opening. 
Full medical (including obstetric, gastrointestinal, anal surgical and 
continence) history and proctosigmoidoscopy are necessary to gain information 
about sphincter strength and to exclude associated conditions. 
CLINICAL ASSESSMENT : 
  The key points to determine are 
  the site of the internal opening; 
  the site of the external opening(s);  
 the track;  
 conditions complicating the fistula.  
Palpable induration between external opening and anal margin suggests a 
relatively superficial track, whereas supralevator induration suggests a primary 
track above the levators or high in the roof of the ischiorectal fossa, or a high 
secondary extension.  
Intersphincteric fistulae usually have an external opening close to the anal 
verge. 
  
GOODSALL’S RULE  used to indicate the likely position of the internal 
opening according to the position of the external opening(s), is helpful but not 
infallible. 
 
  Goodsall's rule can be used as a guide in determining the location of the 
internal opening. 
 
  In general, fistulas with an external opening anteriorly connect to the internal 
opening by a short, radial tract.  
 
Fistulas with an external opening posteriorly track in a curvilinear fashion to 
the posterior midline.  
 
However, exceptions to this rule often occur if an anterior external opening 
is greater than 3 cm from the anal margin. Such fistulas usually track to the 
posterior midline. 
 
   The site of the internal opening may be felt as a point of induration or seen 
as an enlarged papilla. Probing in an awake patient is painful, unhelpful and can be 
dangerous.  
Full examination under anaesthesia should be repeated before surgical 
intervention. 
  Dilute hydrogen peroxide, instilled via the external opening, is a very useful 
way of demonstrating the site of the internal opening. 
Dilute methylene blue is useful in patients with multiple external openings or 
when high secondary track is suspected 
  
Probing: 
 
 
  Gentle use of probes and a finger in the anorectum usually delineates 
primary and secondary tracks and their relations to the sphincters. 
 
Lockhart -Mummery fistula probes are useful but must be advanced very 
cautiously since their tips are not particularly blunt. 
 
Retrograde probing is preferred where the fistula probe is passed from anal 
canal to perineum. 
 
Prograde probing other than which follows a  course parallelor <20  degrees 
to anal canal skin is either in a secondary track from a trans sphincteric fistula 
(pushing causes an extrasphincteric fistula ) or a long inter sphincteric fistula. 
 
Any concerns about fistula topography at clinical examination or 
examination under anaesthesia (more common after previous unsuccessful surgery) 
should prompt further investigations before surgical intervention 
 
 
 
INVESTIGATIONS 
INSPECTION 
Patient is examined in the left lateral (Sims) position with the buttocks 
overlying the edge of the examination couch and with the axis of the torso crossing, 
rather than parallel with, the edge of the couch. 
 
  Alternatively, in younger patients, the prone jackknife or knee–elbow 
positions may be used. 
 
The buttocks are gently parted to allow inspection of the anus and perineum:  
 the presence of any skin lesions and whether they are confined to the 
perineum or evident elsewhere on general examination, e.g. psoriasis, lichen planus, 
or on genital examination, e.g. warts, candidiasis, lichen sclerosus et atrophicus, the 
vesicles of herpes simplex virus (HSV); 
 evidence of anal leakage; 
 whether the anus is closed or patulous. 
 Presence of external opening in fistula or hemorhoidal mass in piles 
  
Pain on parting the buttocks, perhaps together with the presence of a sentinel 
tag, may indicate the presence of an underlying fissure, but may also prompt the 
need for examination under anaesthesia to exclude more suspicious pathology, for 
example squamous cell carcinoma of the anal canal. 
 
Sphincter length, resting tone and voluntary squeeze are also assessed. 
These may be more objectively assessed by manometry. 
 
PROCTOSCOPY: 
  Proctoscopy is performed with the patient in the same position, allows a 
detailed inspection of the distal rectum and anal canal. 
 
SIGMOIDOSCOPY: 
Although sigmoidoscopy is strictly an examination of the rectum, it should 
always be carried out even when an anal lesion has been confirmed. Rectal 
pathology, e.g. colitis or carcinoma, is frequently associated with an anal lesion 
 
 
  
IMAGING 
Trans Anal (endo anal) ultrasonagram: 
Requires a 7 and 10 mHz probe. 
Defines the internal opening,intersphincteric sepsis ,defects in the sphincter. 
Gives useful information about sphincter integrity – the knowledge so gained may 
well influence surgical strategy. 
  Endoanal ultrasound, especially with hydrogen peroxide, can also be used to 
delineate fistulae, is more accurate than clinical examination, is useful to determine 
whether a fistula is relatively straightforward or not.  
Disadvantage : 
Anatomical definition beyond the internal sphinceter is poor-perineal 
components of fistula not visualised in most patients. 
Fistulography : 
Fistulography and computed tomography (CT) both have limitations but are useful 
techniques if an extrasphincteric fistula is suspected 
Fistulography consists of injecting a water soluble contrast via the external opening 
to identify abscess cavities and course of the tract. 
Reserved only for complex fistulas now a days. 
Invasive procedure and is Superceded by MRI 
Magnetic resonance imaging : 
Regarded as the investigation of choice to define complex anorectal sepsis 
and fistulas. 
 
Magnetic resonance imaging (MRI) is acknowledged to be the ‘gold 
standard’ for fistula imaging, but it is limited by availability and cost and is usually 
reserved for difficult recurrent cases. The great advantage of MRI is its ability to 
demonstrate secondary extensions, which may be missed at surgery and which are 
the cause of persistence.  
 
For optimum assessment for anal canal fistulae the following are used, 
 short-inversion-time inversion recovery (STIR) 
 gradient-echo T1-weighted with or without gadolinium-based intravenous 
contrast material 
 spin-echo T1-weighted 
 spin-echo T2-weighted with saline instillation (MR fistulography) 
 
   Because MRI can provide multiplanar visualization of the sphincter muscles, 
differentiation of supralevator from infralevator lesions is easier. 
A prospective study to determine the impact of MRI with primary fistulas, 
found that MRI changed the surgical approach in 10%.  
In another study with respect to recurrent fistulas, recurrence rates were 
found to be higher for those surgeons who never used MRI. 
They concluded that MRI-guided surgery can decrease recurrence rates by 
75% in surgery for recurrent fistulas. 
  
 ST JAMES `S UNIVERSITY HOSPITAL MR IMAGING 
CLASSIFICATION 
0 Normal appearance 
1 Simple linear intersphincteric fistulas 
2 
Intersphincteric fistula with abscess or 
secondary tracks 
3 Transsphincteric fistula 
4 
Transsphincteric fistula with abscess or 
secondary tracks in ischiorectal fossa 
5 Supralevator or translevator disease 
 
 
TREATMENT 
Patients with minimal symptoms, especially if they have compromised 
sphincters, may be managed expectantly.  
 
Eradication of sepsis requires surgery, the aim of which must be balanced 
with the preservation of continence. 
 
FISTULOTOMY  
Laying open -rule promulgated by John of Arderne more than 600 years ago. 
Fistulotomy  is the surest way of getting rid of a fistula, but, by definition, it 
involves division of all those structures lying between the external and internal 
openings.  
 
It is therefore applied mainly to intersphincteric fistulae and trans-sphincteric 
fistulae involving less than 30 per cent of the voluntary musculature (but not 
anteriorly placed fistulae in women no puborectalis anteriorly). 
 
PROCEDURE : 
After full examination under anaesthesia in the lithotomy or prone jack-knife 
position, during which the internal opening should have been identified, a grooved 
fistula probe is passed from the external to the internal opening , the amount of 
sphincter below and above the probe is noted and, if indicated, the track is laid 
open over the probe. 
  Granulation tissue is curetted and sent for histological appraisal and the 
wound edges are trimmed. Secondary tracks, often identified as granulation tissue 
that persists despite curettage, should be laid open or drained. Marsupialisation 
reduces wound size and speeds up healing. 
 
Primary tracks crossing the external sphincter more deeply have been 
managed with good outcomes by fistulotomy and immediate reconstitution of the 
divided muscle – failure to eradicate all sepsis and subsequent breakdown of the 
repair, however, are very problematic 
 
Staged fistulotomy may be carried out in which secondary tracks are laid 
open and only part of the sphincter enclosed by the primary track is divided, with 
the remainder encircled by a loose seton.  
 
After sufficient time for healing of the wound and fibrosis, the seton-
enclosed track is divided at a second stage. 
 
  
FISTULECTOMY 
Involves Coring out of the fistula, usually by diathermy cautery. It allows 
better definition of fistula anatomy than fistulotomy, especially the level at which 
the track crosses the sphincters and the presence of secondary extensions. 
Parks fistulectomy - Parks described aconservative operation in which  the 
lower  half of the Internal sphincter was divided to eradicate the causative. infected 
analgland and the peripheral fistula was managed. by using coring out, curettage,  
or incision. and. curettage.  
  The major advantage of this technique is the preservation of the external 
sphincter. 
  For fistulas crossing the external sphincter at a high level,the lower portion 
of this muscle must be divided to allow adequate drainage and healing. 
   Parks believed that it is in these fistulas that such a conservative approach 
isadvantageous over the classic layout-open technique. 
 
 
SETON : 
Latin: seta, bristle 
Two types -may be loose or cutting setons 
1.Loose setons-Loose setons are tied such that there is no tension upon the 
encircled tissue; there is no intent to cut the tissue. 
2.Tight or cutting setons - placed with the intention of cutting through the enclosed 
muscle 
A variety of materials have been used, but the seton should be non-absorbable,non-
degenerative and comfortable. silk or other nonabsorbable suture material are 
commonly used 
 
Loose seton : 
Loose seton is passed across the sphincteric component of the primary track 
to simplify the fistula and allow fibrosis. 
•   As part of a staged fistulotomy. 
•   As part of a therapeutic strategy to preserve the external sphincter in trans-
sphincteric fistulae 
 Long-term palliation to avoid septic and painful exacerbations by 
establishing effective drainage. 
 
Cutting Seton : 
Cutting setons aim to achieve the high fistula eradication rates associated 
with fistulotomy, but without the degree of functional impairment endowed by 
division of the sphincters at a single stage. 
  The enclosed muscle is gradually severed (‘cheese wiring through ice’) such 
that the divided muscles do not spring apart, and the site of the fistula track is 
replaced by a thin line of fibrosis as it is brought down. 
A type of cutting seton used in India  in old ages , known as Kshara sutra, in 
which a specially prepared seton thread burns through the enclosed tissue. 
 
 Indications for seton use include the following:  
1.Promote fibrosis around a complex anal fistula 
 
2. Anterior fistulas in women 
 
3.Patient with AIDS  
 
4.Elderly patients with weakened sphincter muscles 
 
5.Multiple fistulas  
 
6.Multiple  perianal surgeries 
 
  
PROCEDURE : 
Based on the belief that the pathogenesis of most anal fistulas is 
cryptoglandular disease, the internal sphincter should be divided from the level of 
the internal opening at the dentate line to its distal end in order to eradicate the 
source.  
The over lying  skin is divided From this point to the secondary fistulous 
opening. A nonabsorbable suture is then threaded through the fistulous tract. Seton 
is tightened at  2to4 week intervals until the seton has completely cut through the 
muscle. 
  Due to repeated handling during cleansing, thepatient will eventually ‘‘saw’’ 
through the muscle. The muscle  is divided at a second stage 6to8 weeks later. 
Appropriate timing of transection of the sphincter subsequent to seton placement is 
essential for sufficient fibrosis to ensure sphincter function 
  
TREATMENT OF SPECIFIC TYPES 
Intersphincteric Fistulae 
1.Uncomplicated : 
 
Disease in the middle of the anal canal by division of the lower half of the 
internal sphincter.This treatment seldom causes any disturbance of functio 
 
  
2.High blind tract- 
 
 
Dividing the internal sphincter  as high as the high blind tract ascends. This 
procedure will unroof the infected anal gland and the blind extension. Little 
disturbance of continence will ensue because the edges of the sphincter are held 
together by fibrosis around the fistulous tract. 
  Failure to recognize this upward extension might result in a recurrence 
 
 
 3.High Tract with Rectal Opening- 
 
The whole of this tract is intersphincteric ,and the tissue medial to. it usually. 
can be divided without risks. However, it is. easy to believe mistakenly that the 
tract passes out side the external sphincter. If the probe passes 
straight.upward(i.e.,parallel to the anal canal), the. direction. of.  this.  passage. 
often helps in making the diagnosis  
In the case of an intersphincteric tract, the probe passes. close to the lumen of the 
anal canal 
 4. High Tract Without perineal Opening: 
 
 
Treatment consists of laying the tract open into the rectum.In addition,  the 
lower portion of the tract must be incised in the middle of the anal because ;if this 
portion is left behind,recurrence will ensure(Fig.19) 
  
5.Extrarectal Extension- 
 
 
Correct treatment is drainage into the rectum. Any attempt to drain into the 
ischioanal fossa will result. in production of a Suprasphincteric fistulae,which is a 
considerably more difficult problem to manage(Fig.20) 
 
 
 
 
 6.SecondarytoPelvicDisease 
 
The prime goal is elimination of the abdominal source, since failure. to do so 
makes cure of the fistula impossible. 
As a rule, no local treatment other than possible curettage of the tract is 
necessary because such a fistula usually. heals once the pelvic disease has been 
removed This disorder is not a true anal fistula; 
Therefore, division of the muscle. is both unnecessary and potentially 
dangerous(Fig.21) 
  
TRANS SPHINCTERIC FISTULA 
1.Uncomplicated Type- 
 
The level at which the tract crosses the external sphincter  determines the 
ease or difficulty encountered in treatment. Most cross at a low level so that laying 
open the fistula will result in division of only the lower portion of the external 
sphincter and the lower half of the internal sphincter; consequently, disturbance of 
function is unlikely. The highest level is just below the puborectalis muscle, at 
which point al lthe external sphincter may need to be divided.  
  
Even so, enough puborectalis muscle usually remains to maintain near-
perfect continence. To preserve sphincter rmuscle, fistulas with tracts crossing at 
high levels may be treated by division of the lower half of the internal sphincter, 
creation of adequate drainage of the fistulous tract, division of only a portion of the 
external sphincter, and insertion of a seton (Fig.38). The externalportion of the tract 
may be treated  with curettage or coring out. 
2.High blind tract- 
 
The treatment of this variety consists of finding the primary tract, which 
passes into the anal canal and laying it open.The high extensions are then provided 
with adequate drainage. 
A greater amount of external sphincter possibly will require division, but the 
amount depends on the level at which the fistulous tract crosses the sphincter. 
Otherwise, the same considerations pertain as with the uncomplicated 
variety(Fig.23) 
  
  
 
SUPRA SPHINCTERIC FISTULA 
1.Uncomplicated- 
 
An uncomplicated suprasphincteric fistula starts in the intersphincteric plane 
in the middle of the anal canal and passes upward to a point above the puborectalis 
muscle.   
It tracks laterally over this muscle and downward between the puborectalis 
and the levatorani muscles into the ischioanal fossa, thus looping over the entire 
sphincter mass.  
Treatment of this fistula by a classic lay-open technique  would result in 
division of the external sphincter and the puborectalis muscle, most likely 
rendering the patient incontinent.  
 
Therefore, it is better to use a modification of a lay-open method in which 
the sphincter mass is divided into successive stages. The fetula itself usually helps 
provide a solution to the problem. As it passes over the puborectalis muscle, 
fibrous tissue is created around it.  
This problem is treated by division of the lower half of the internal 
sphincter(to eradicate the anal gland of origin), creation of adequate drainage of the 
secondary limb, and division of variable amounts (approximately half) of the 
external sphincter. 
 The use of a seton is encouraged , and division of contained muscle,if 
necessary, is performed in stages. Functional results will be better if muscle can be 
preserved.(Fig.24).  
 
  
2 High blind tract- 
 
Treatment is similar to that for the uncomplicated supra sphincteric fistula 
but adequate drainage of the abscess in the supralevator compartment also must be 
established. The supralevator abscess may be bilateral and requires corresponding 
drainage .(Fig.25) 
  
EXTRA SPHINCTERIC FISTULA 
This route lies entirely outside the ring of sphincter muscle. If this tract is 
laid open, total incontinence will result.  
1.Secondary to anal fistula 
`  
The primary tract in the anal canal must be eradicated by division ofthe 
lower half of the internal sphincter. The opening in the rectal wall is closed with 
two or three interrupted nonabsorbable sutures such as wireones or with very 
slowly absorbable sutures such as polyglycolicacid ones.  
 
Adequate drainage of the fistulous tract must be achieved with special 
attention paid to the elimination of pocketing at the apex of the ischioanal fossa or 
supralevator extension. Preoperatively the patient is given a mechanical bowel 
preparation and postoperatively is fed an elemental diet ,thus effectively creating a 
‘‘medical colostomy’’.  
In this manner, the rectal opening can be sutured without subsequent break 
down, but it may be necessary to create a temporary defunctioning colostomy to 
reduce rectal pressure before complete healing can occur. The colostomy may be 
closed three months later .(Fig.26) 
  
2 . Secondary to trauma- 
 
Treatment consists of removing theforeignbody, establishing adequate 
drainage, and performing a temporary colostomy to reduce the rectal  pressure. 
Cutting any sphincter muscle is not necessary 
 
  
3.Secondary to Specific Anorectal Disease 
 
Are not usually amenable to local treatment; thus, the disease itself must be 
treated, usually with a proctectomy(Fig.28) 
  
4.SecondarytoPelvicInflammation 
 
No muscle requires division. The same principles pertain as In a patient with 
intersphincteric  fistula secondary to pelvic disease(Fig.29). 
For patients with an extrasphincteric fistula associated with severe pelvic     
sepsis when pelvic dissection would encounter operative danger at the 
circumferential margins where ureter, blood vessels, vagina, and prostate can all be 
damaged,Maxwell-Armstrong and Phillips described the successful use of the  
  
Soave procedure . 
Abdominal dissection proceeds to the point of maximum difficulty, the 
bowel is transected , a distal mucosectomy is performed from above and/or below 
and a colo anal anastomosis is performed. If there is a stricture, forced dilatation is 
performed .If a stricture is found, dilatation is performed  withHegar dilators 
 
  
ADVANCEMENT RECTAL FLAP 
For patients whose fistulas cross the sphincter muscle at a high level 
(e.g.,high trans sphincteric and supra sphincteric levels), there is always the 
concern that division of the muscle below the tract will result in significant 
alterations in continence.  
Thus, there is renewed interest in the advancement rectal flap technique for 
treating those patients to preserve fecal continence while eradicating the complex 
fistula. 
Indications include patients with multiple fistulas, both cryptogenic and 
rectovaginal involving one-third of the circumference of the anal canal, also in a 
crohns disease. 
Principles of repair include excision of the internal opening in the anal canal, 
precise anatomic definition and excisionorcurettageofthemain tracts, advancement 
of a flap of mucosa and submucosa of rectum beyond the original internal opening, 
and tension-free suture of the flap to the   anal canal distal to the original opening. 
The attractive features of this  repair include the fact that no sphincter 
requires division, contour defects are avoided, the pain is less because there is no 
perineal wound , and healing is more rapid. 
The median time to recurrence was eight weeks but recurrences were 
observed in 15.7% of patients > 3 years after repair 
  
 
Sleeve endoanal advancement flap: 
The operative technique is adapted from the intersphincteric proctectomy. A 
circumferential incision is made just distal to the internal openings and hence just 
distal to the dentate line. 
  Uninvolved portion of the circumference need not  be mobilized. Fistulous 
tracts are divided as encountered. Excluded tracts are curetted, disrupting and 
removing epithelialized or granulation tissue. External openings are enlarged to 
ensure drainage. The distal diseased tube is amputated and the proximal wall is 
anastomosed to the initial line of incision. 
Dermal Island Flap Anoplasty: 
Robertson and Mangione described a technique of cutaneous advancement 
flap associated with suture closure of the internal opening and external drainage. 
V-Y advancement flap to cover  the internal opening leaving the site of the 
external opening for drainage while preserving the internal and external sphincter. 
They concluded, the results of anocutaenous advancement flap in patients with 
none or only one previous attempt at repair are moderate. For patients who have 
undergone two or more previous attempts at repair, the outcome is poor. Based on 
relatively low healing rate and deterioration of continence, this procedure seems 
less suitable for high trans-sphincteric fistulas than peranal mucosal advancement 
flap repair. 
Biological methods : 
Cause healing of the track by providing a naturally derived extracellular 
matrix to act as scaffolding, allowing in-growth of host tissue for incorporation and 
remodeling.  
1. Fibrin glue 
Fibrin glue is a noveltreatment for anal fistulas.Fibrin glue is a 
multicomponent system with the primary agents being human pooled plasma 
fibrinogen and thrombin. Once prepared, the fibrin glue components are injected 
into the anal fistula track. Over a matter of minutes, the glue hardens and fills the 
entire track. The fistula tract  is identified and curetted. Fibrin glue is injected into 
the fistula tract .Short-term success rates of 70%–74% 
2.Anal plug: 
The newest modality of therapy for the treatment of fistula in-ano of crypto 
glandular origin is the Surgisis AFP (Cook Surgical inc.) anal plug introduced by 
Armstrong. The plug is cone shaped and made from porcine small intestinal 
submucosa. When placed in the fistula tract it is   proposed to serve as a bioscaffold 
for native tissue regeneration and hence occlude the fistulous tract. 
Each fistula tract was irrigated with hydrogen peroxide and closed using a 
rehydrated AFP which is inserted into the primary opening, cut to the length and 
sutured in place.  At a follow up of 1to 24 months (median10months),the complete 
closure  rate was 83%. Failures were due to plug ‘‘fallout’’ (6%), multiple tracts 
(4%), persistent drainage (4%), and late recurrence (2%) at six months 
postoperatively. 
Failures occurred more often in multiple tracts. 
 
 
 
 
 
 
 
LIGATION OF INTERSPHINCTERIC FISTULA TRACT 
PROCEDURE (LIFT) 
 
Sphincter sparing surgery based on the secure closure of the internal opening 
and removal of infected cryptoglandular tissue in the inter sphincteric space. 
TECHNIQUE: 
1. Bowel preparation  
2. Prone jack knife position 
3. Internal opening identified , 1.5 -2cm curvilinear incision is made at the inter 
sphincteric plane and dissection is carried close external sphincter.  
4. Intersphincteric tract dissected and ligated close to internal opening.l 
5. Tract excision confirmed by injection or probing of external opening 
6. Granulation tissue curretted and external opening sutured through the 
intersphincteric wound . 
7. Incision closed. 
Disadvantage :early fistulous abscess without well formed intersphincteric tract is 
not suitable for treatment. 
Success rates 58-94% have been reported.  
VAAFT TECHNIQUE 
“Video-Assisted Anal Fistulous Treatment” (VAAFT)  introduced by 
Meinero. 
The VAAFT procedure is performed with the use of a fistuloscope, which 
allow a search for the correct location of the internal fistula, as well as the study of 
the fistulous path in search of collections or accessory paths”. 
FISTULOSCOPE 
 
 
 
IDENTIFICATION OF TRACT 
“The patient is placed in the lithotomy position after spinal anesthesia. Then, 
the surgeon identifies the external orifice through which the fistuloscope will be 
introduced. The infusion of glycine solution is started, enabling the direct 
visualization of the fistulous lumen by a continuous jet of irrigation solution. The 
device is introduced in search of the fistulous tract and of the internal orifice, as 
well as of accessory paths. After identifying the internal opening, it is isolated with 
sutures, still leaving the orifice open” 
PROCEDURE : 
“In this phase the surgeon proceeds with the fulguration of the inner side of 
the fistulous tract. Using the monopole electrode, proceeds with destruction of all 
the tract under direct vision with cauterization of the bed. The procedure starts near 
the internal orifice, retreating little by little, until achieving the external orifice, 
concluding the cauterization. Following this, the necrotic material is removed by 
brushing and flushing with the washing solution. Finally, the internal orifice repair 
is pulled and, with the use of a stapler, the internal orifice closure is achieved; or a 
cutaneous-mucosal flap or orifice synthesis is performed”. 
“In his study, Meinero obtained a good response in 73.5% of patients after 2-
3 months. In patients without fistula healing, 26.5% were reoperated by VAAFT. 
Overall, a healing response of 87.1% was obtained”. 
 
POSTOPERATIVE CARE 
"The post operative care of the wound may be as important as the operative 
procedure in treating a patient with a fistula in-ano 
The primary goals are sound healing from the depths of the wounds and 
prevention of the contact and premature healing of opposing skin edges. A regular 
diet is prescribed, and analgesics are administered as needed. 
A large stool created by bulk-forming agents effects a physiologic dilatation" 
 
COMPLICATIONS 
Early complications include urinary retention, hemorrhage, fecal impaction, 
and thrombosed external hemorrhoids,  occur in less than 6% of cases. 
Later complications such as pain, bleeding, pruritus, and poor wound healing 
have been reported in 9% of patients. 
Anal stenosis may occur and is usually the result of loose stools allowing 
healing of the anal canal by scar contracture. 
Mucosal prolapse caused by extensive division of sphincter muscle may also 
occur and can be treated by band ligation, sclerosis, or excision. 
With attention to both operative detail and postoperative follow-up, these 
complications can be reduced to a minimum .  
RECURRENCE 
“The most common cause of recurrence of an anal fistula is failure to 
identify and treat the primary internal orifice. The result is that the causative 
infected anal gland in the intersphincteric space is not eradicated. 
Failure to detect and treat lateral or upward extensions also may be followed 
by recurrence.Failure to open the fistulous tract for fear of causing incontinence 
also may result in recurrence 
Premature closure of fistulotomy wounds may result in early 
recurrence.Also, when the etiologic factor of the fistula is a specific disease, such 
as Crohn’s disease, recurrences are not infrequent” 
CAUSES OF ANAL IN CONTINENCE AFTER OPERATION FOR ANAL 
FISTULA 
 
1.Division of Anorectal Muscle 
  Complete severance of the anorectal ring results in total incontinence. 
Division of lesser amounts of sphincter muscle may result in varying degrees of 
partial incontinence, depending on the state of the sphincter muscle at the outset 
and the location of the myotomy. 
2.Injury to Sphincter Mechanism  
Cutting the inferior rectal nerve results in impaired continence, but control 
may be acceptable with only one nerve 
3.Prolonged Packing After Anorectal Surgery causes fibrosis of sphincter 
SPECIAL CONSIDERATIONS 
SUPERFICIAL FISTULA  
A certain number of low fistulas are not associated with anal gland infection. 
They are the submucous or subcutaneous fistulas that are associated with the 
bridging of fissure edges in the midline posteriorly or fistulas that occur 
occasionally in a patient with a hemorrhoidectomy wound. Treatment is 
accomplished very simply through a lay-open technique or excision and primary 
closure 
PRIMARY Vs. SECONDARY FISTULOTOMY: 
Controversy continues to exist as to whether a primary.Fistulotomy should 
be used in the treatment of anorectal abscesses.Some surgeons favor a one-stage 
procedure in which incision and drainage are combined with fistulotomy. They 
believe that this procedure will eradicate the origin of the infectious process, there 
by almost eliminating the development of recurrent abscesses and anal fistulas, 
which they believe are otherwise inevitable.  
Proponents of a more conservative approach prefer a two-stage procedure in 
which incision and drainage are performed initially, followed by fistulotomy at a 
later date only if necessary. They argue that the need for an operation will not 
occur for certain. 
Thus, patients would be exposed needlessly to the potential risk of 
incontinence, a dreaded possible consequence of fistulotomy, especially in the 
presence of acute inflammation 
MUCINOUS ADENOCARCINOMA ARISING FROM FISTULA IN ANO 
 
Extremely rare entity. 
Diagnostic criteria are 
1. Fistula should antedate carcinoma by 10 years 
2. Only tumor present should be secondary to extension from carcinoma into the 
fistula.  
3. Internal opening should be in the anal canal and not into the tumor itself.  
MRI - Characteristic features 
 Fistula Between the mass and anus 
 Pools of extracellular mucin lined by columns of malignant cells , cords,  
vessels producing a mesh like structure.  
Managed by Abdomino perineal resection , chemo radiation or both 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CROHN’S DISEASE: 
  
  Most common perianal manifestation (6-34%) . 
          38% heal spontaneously 
Medications  
1.antibiotics – ciprofloxacin,metronidazole 
2.Immunomodulators – steroids ,azathioprine,infliximab 
 
 
Surgery 
 Low fistula with simple tracts in absence of active proctitis 
 Complex with high anal fistula  is managed conservatively or seton 
placement to limit suppuration 
 Advancement flaps in the absence of rectal disease 
 
HIV POSITIVE INDIVIDUALS 
 
Wound healing affected due to altered locoregional defenses 
Asymptomatic fistula are managed conservatively 
High complex fistulas are managed with setons  
Table 1: Baseline characteristics of the study subjects: 
S.No Parameter 
Fistulotomy 
group 
(n = 30) 
Fistulectomy 
group 
(n = 30) 
P value 
1 Age (Year)
#
 41.73 (12.61) 39.43 (10.81) 0.451 (NS) 
2 Sex : 
 
          Male (%) 28 (93.33) 25 (83.33) 
0.423 (NS) 
Female (%) 2 (6.67) 5 (16.67) 
3 Diagnosis: 
 
Inter-sphincteric 
(%) 
25 (83.33) 20 (66.67) 
0.232 (NS) 
Trans-
sphincteric (%) 
5 (16.67) 10 (33.33) 
 
Foot note: N = 30 patients / group. Data are expressed as n (%) except ‘#’ where 
data are expressed as Mean (SD). Unpaired ‘t’ was used to test significance 
between the groups for age. Chi-square test was used to test the significance of 
difference between the proportions of sex and diagnosis pattern of two groups. NS 
= Not significant. 
1. AGE – Age distribution among the 2 groups were similar with a mean age of 
41.73 among fistulotomy group and 39.43 among the fistulectomy group 
2.  SEX  - only 7 patients wer found to be of female gender among 60 in study 
and percentage of male to female patients in each group were similar  ( p value 
0.423 ns) 
3. DIAGNOSIS – our study included only low anal fistula ,hence only 2 types 
are included ; inter sphincteric more common than trans sphincteric; no significant 
difference was noted among distribution of cases in the 2 groups ( p value 0.232 ns) 
Figure 1: Age distribution between fistulotomy and fistulectomy group 
 
Bar diagram representing the age distribution between fistulotomy and 
fistulectomy group. Data are expressed as Mean (SD). Bar represents the mean and 
error bar represents the SD. N = 30 patients/ group. Unpaired ‘t’ test was used to 
test the significant difference and no difference was found. 
Table 2: Treatment difference between the fistulotomy and fistulectomy group: 
S.No Parameter 
Fistulotomy 
group 
(n = 30) 
Fistulectomy 
group 
(n = 30) 
P value 
1 Pain (Score) 3.5 (1.75, 6.25) 4 (2, 7) 0.437 (NS) 
2 Bleeding (No of pads soaked) 1 (1, 2) 1 (1, 2) 0.191 (NS) 
3 Infection: 
 
         No infection (%) 25(83.33) 13 (43.33) 
0.002* 
         Serous discharge from the wound (%) 5(16.67) 17 (56.66) 
4 Incontinence: 
 
        No incontinence (%) 20 (66.67) 21 (70) 
0.999 
        Incontinence for flatus (%) 10 (33.33) 9 (30) 
5 Time to heal (Days) 40.27 (9.39) 49.57 (12.21) 0.0016
#
 
  
Data are expressed as Median (Interquartile range) for ‘Pain & bleeding’, as proportion n (%) for ‘infection & 
incontinence’ and as mean (SD) for ‘time to heal’. N = 30 patients /group. Mann Whitney ‘U’ test was used to test the 
difference between the groups for ‘pain’ and ‘bleeding’. Chi-square test was used to test to difference between the 
proportions for infection and incontinence. Unpaired ‘t’ test was used to test the significant difference between the 
groups for ‘time to heal’. ‘*’ and ‘#’ indicate p < 0.05. NS = Not significant.  
Figure 2: Difference in pain perception by patients during postoperative 
period between fistulotomy and fistulectomy group. 
 
 
 
 
 
 
 
 
Box and Whisker plot diagram representing the pain perception by patients 
during postoperative period in fistulotomy and fistulectomy group. Data are 
expressed as Median (IQ). Central line in the box represents the median 
value of the score and the whisker represents the interquartile range (25
th
 
percentile to 75
th
 percentile). N = 30 patients/ group. Mann Whitney U test 
was used to test the significant difference and no difference was found. 
Pain in the post operative period was also insignificant among the 2 groups 
( p value 0.437 ) 
Figure 3: Difference in occurrence of wound infection in post-operative 
between fistulotomy and fistulectomy group. 
 
 
Stacked Bar diagram representing occurrence of wound infection in post-
operative between fistulotomy and fistulectomy group. Data are expressed as 
proportion (%). N = 30 patients/ group. Chi-square test was used to test to 
difference between the proportions for infection and significant difference ( 
p = 0.002) was found between the groups. 
Statistically significant increased infection rate among the fistulectomy 
group was noted (p value 0.002). 
 
Figure 4: Difference in time taken for operative wound to heal 
completely between  
Fistulotomy and Fistulectomy group. 
 
 
 
 
 
 
 
 
Bar diagram representing difference in time taken for operative wound 
to heal completely between fistulotomy and fistulectomy group. Data are 
expressed as Mean (SD). Bar represents the mean and error bar represents 
the SD. N = 30 patients/ group. Unpaired ‘t’ test was used to test the 
significant difference and significant difference (p = 0.0016) was found. 
Time to heal was shorter among the fistulotomy group which was 
statistically significant( p value 0.0016)  
 
CONCLUSION 
1. Fistula in ano is common in age group 40- 50 years in our study 
with mean age of 40 years among the two study group. 
2. More common in males, with a male to female ratio of 8: 1 
3. Inter sphincteric fistula is more common than transphincteric 
among the simple low anal fistula included in the study with a ratio of 3 : 
1.  
4. Postoperative pain scores in the two groups were similar.  
5. Wound infection was found to be higher in fistulectomy group.  
6. 30 % of cases showed incontinence to flatus with no significant  
difference between 2 groups  
7. Time for wound healing was significantly shorter among the 
fistulotomy group compared with fistulectomy group. 
8. Recurrence could not be assessed due to irregular follow up at 3 
months interval and short duration of the study 
  Hence it is concluded that fistulectomy has no advantage over 
fistulotomy in postoperative period and short term follow up for 
patients with simple low anal fistula 
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PROFORMA 
 
Name:                                                                   Hospital No : 
 
Age    :                                                                   Case No       : 
 
Sex     :           occupation   : 
 
Complaints : 
 
 
 
H/o present illness: 
 
 
Past illness: 
ASSOCIATED RISK FACTORS; 
 HT, DM,CAHD, COPD, SMOKER, ALCOHOLIC,PREVIOUS 
SURGERY 
 
 
  
 
General examination : 
 Build and nourishment: 
 Height and weight: 
  
  
 
Systemic examination : 
CVS             : 
 RS                : 
CNS             : 
 Pulse 
BP 
  
  
ABDOMEN: 
 
Per rectal examination: 
 
Proctoscopy 
INVESTIGATIONS 
Hemoglobin  DC    TC P L E  
Blood Sugar  BT    CT 
Blood Urea 
Serum Creatinine 
Serum Electrolytes      
Na+        Cl- 
K+          Hco3- 
Sr Albumin 
Sr globulin 
VCTC 
CXR 
Fistulogram 
MRI 
DIAGNOSIS; 
PROCEDURE DONE; 
DURATION OF STAY; 
  
POST OPERATIVE COMPLICATIONS; 
 Bleeding 
  Pain 
 Wound healing 
 Infection 
 Incontinence (feces/flatus) 
 
RESULT; 
 
 
  
INFORMED CONSENT FORM 
(This is only a guideline – Relevant changes to be made as per the study 
requirements) 
Title of the study: 
“_______________________________________________________”_ 
Name of the participant:-
____________________________________________________ 
Name of the Principal (Co-investigator): 
_______________________________________ 
Name of the 
Institution:_____________________________________________________ 
Name and address of the sponsor/agency (ies) (if 
any):____________________________ 
_____________________________________________________________
____________ 
Documentation of the informed consent. 
I _________________________________have read the information in this 
form (or it has been read to me). I was free to ask any questions and they 
have been answered. I am over 18 years of age and , exercising my free 
power of choice, hereby give my consent to be included as a participant in 
“_____________________________________________________________
___________________ 
_______________________________________________________”(title of 
the study). 
  
1. I have read  and understood this consent form and the information 
provided to me . 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the 
investigator. 
5. I have been informed the investigator of all the treatments I am taking 
or have taken in the past ___________ months including any native 
(alternative) treatment. 
6. I have been advised about the risks associated with my participation in 
this study* 
7. I agree to cooperate with the investigator and I will inform him / her 
immediately if I suffer unusual symptoms.* 
8. I have not participated in any research study within the past 
_______________ months.* 
9. I have not donated blood within the past__________ months – Add if 
the study involves extensive blood sampling.* 
10. In am aware of the fact that I can opt out of the study at any time 
without having to give any reason and this will not affect my future 
treatment in this hospital .* 
11. I am also aware that the investigator may terminate my participation in 
the study at any time for any reason, without my consent.* 
12. I hereby give permission to the investigators to release the information 
obtained from me as result of participation in this study to the 
sponsors, regulatory authorities, Govt. Agencies, and IEC. I 
understand that they are publicly presented. 
13. In have understand that my identity will be kept confidential if my 
data are publicly presented. 
14. In have had my questions answered to my satisfaction. 
15. I have decided to be in the research study. 
I am aware that if I have any question during this study, I should contact 
the investigator. By signing this consent form I attest that the information 
given in this document has been clearly explained to me and understood 
by me , I will be given a copy of this consent document. 
 
 
S.NO 
Case 
No 
Patient 
ID 
Age Sex Procedure 
Procedure 
Code 
Diagnosis 
code 
Pain 
Score 
Pain 
code 
Bleeding 
(No of 
Pad 
soaked) 
Bleeding 
code 
Infection 
Infection 
code 
Incontinence 
Incontinence 
code 
Time to 
heal 
(Days) 
1 1 14614 34 F Fistulotomy 1 1 6 2 1 1 Nil 1 Nil 1 34 
2 2 19464 32 M Fistulotomy 1 1 1 1 2 2 Nil 1 Nil 1 40 
3 3 24690 65 M Fistulotomy 1 1 1 1 1 1 Serous 2 Flatus 2 50 
4 4 28983 37 M Fistulotomy 1 1 7 2 1 1 Nil 1 Flatus 2 30 
5 5 47047 18 F Fistulotomy 1 1 3 1 1 1 Nil 1 Nil 1 32 
6 6 5777 45 M Fistulotomy 1 2 5 2 1 1 Nil 1 Flatus 2 45 
7 7 9347 45 M Fistulotomy 1 1 5 2 2 2 Serous 2 Flatus 2 55 
8 8 13017 29 M Fistulotomy 1 1 7 2 1 1 Nil 1 Nil 1 35 
9 9 14928 55 M Fistulotomy 1 1 1 1 1 1 Nil 1 Nil 1 40 
10 10 13012 30 M Fistulotomy 1 1 7 2 1 1 Nil 1 Nil 1 42 
11 11 14320 40 M Fistulotomy 1 1 2 1 2 2 Nil 1 Nil 1 30 
12 12 28010 36 M Fistulotomy 1 1 6 2 1 1 Nil 1 Nil 1 28 
13 13 29605 58 M Fistulotomy 1 2 8 3 2 2 Nil 1 Flatus 2 50 
14 14 34171 28 M Fistulotomy 1 1 1 1 1 1 Nil 1 Nil 1 30 
15 15 3880 63 M Fistulotomy 1 2 7 2 1 1 Serous 2 Nil 1 45 
16 16 18193 38 M Fistulotomy 1 1 1 1 2 2 Nil 1 Nil 1 42 
17 17 18169 29 M Fistulotomy 1 1 7 2 1 1 Nil 1 Nil 1 36 
18 18 19239 50 M Fistulotomy 1 1 1 1 1 1 Nil 1 Flatus 2 58 
19 19 21387 34 M Fistulotomy 1 1 3 1 1 1 Nil 1 Nil 1 30 
20 20 21420 45 M Fistulotomy 1 1 5 2 1 1 Nil 1 Flatus 2 45 
21 21 21530 55 M Fistulotomy 1 1 2 1 2 2 Nil 1 Flatus 2 30 
22 22 30821 22 M Fistulotomy 1 1 5 2 1 1 Serous 2 Nil 1 40 
23 23 48693 38 M Fistulotomy 1 1 2 1 2 2 Nil 1 Nil 1 51 
24 24 18169 29 M Fistulotomy 1 1 6 2 2 2 Nil 1 Nil 1 64 
25 25 19239 50 M Fistulotomy 1 1 3 1 1 1 Serous 2 Flatus 2 71 
26 26 21387 34 M Fistulotomy 1 1 3 1 1 1 Nil 1 Nil 1 50 
27 27 21384 45 M Fistulotomy 1 2 1 1 1 1 Nil 1 Flatus 2 34 
28 28 26919 55 M Fistulotomy 1 1 4 2 1 1 Nil 1 Nil 1 50 
29 29 3880 63 M Fistulotomy 1 2 8 3 2 2 Nil 1 Nil 1 60 
30 30 2829 50 M Fistulotomy 1 1 2 1 1 58 58 58 58 58 58 
 
S.NO 
Case 
No 
Patient 
ID 
Age Sex Procedure 
Procedure 
Code 
Diagnosis 
code 
Pain 
Score 
Pain 
code 
Bleeding 
(No of 
Pad 
soaked) 
Bleeding 
code 
Infection 
Infection 
code 
Incontinence 
Incontinence 
code 
Time 
to 
heal 
(Days) 
31 31 7260 42 M Fistulectomy 2 2 1 1 2 2 Nil 1 Nil 1 38 
32 32 10933 42 M Fistulectomy 2 1 5 2 1 1 Nil 1 Nil 1 40 
33 33 11932 47 M Fistulectomy 2 1 4 2 2 2 Serous 2 Flatus 2 35 
34 34 15345 42 M Fistulectomy 2 1 1 1 1 1 Nil 1 Nil 1 42 
35 35 15341 38 M Fistulectomy 2 1 9 3 1 1 Nil 1 Nil 1 28 
36 36 15386 22 M Fistulectomy 2 1 2 1 2 2 Nil 1 Nil 1 40 
37 37 24518 50 M Fistulectomy 2 1 6 2 1 1 Serous 2 Nil 1 55 
38 38 26200 46 M Fistulectomy 2 2 4 2 1 1 Nil 1 Flatus 2 62 
39 39 26222 65 M Fistulectomy 2 2 4 2 1 1 Serous 2 Flatus 2 70 
40 40 27419 25 M Fistulectomy 2 1 2 1 1 1 Serous 2 Nil 1 30 
41 41 27417 24 M Fistulectomy 2 1 1 1 1 1 Serous 2 Nil 1 45 
42 42 32535 45 M Fistulectomy 2 1 7 2 1 1 Nil 1 Flatus 2 55 
43 43 2598 28 M Fistulectomy 2 2 7 1 1 1 Serous 2 Nil 1 40 
44 44 13771 28 F Fistulectomy 2 1 2 1 2 2 Nil 1 Nil 1 45 
45 45 1570 45 M Fistulectomy 2 2 8 3 2 2 Nil 1 Flatus 2 40 
46 46 40367 36 M Fistulectomy 2 2 9 3 2 2 Serous 2 Nil 1 65 
47 47 40368 50 M Fistulectomy 2 2 6 2 1 1 Serous 2 Flatus 2 80 
48 48 43421 38 M Fistulectomy 2 1 2 1 2 2 Serous 2 Nil 1 45 
49 49 48400 35 M Fistulectomy 2 1 5 2 1 1 Serous 2 Nil 1 50 
50 50 50369 49 M Fistulectomy 2 1 7 2 2 2 Nil 1 Nil 1 48 
51 51 35421 28 F Fistulectomy 2 1 9 3 2 2 Serous 2 Nil 1 44 
52 52 7913 45 M Fistulectomy 2 2 4 2 2 2 Serous 2 Flatus 2 58 
53 53 9557 37 M Fistulectomy 2 1 9 3 2 2 Serous 2 Nil 1 60 
54 54 18323 57 M Fistulectomy 2 1 3 1 2 2 Nil 1 Nil 1 72 
55 55 22723 26 F Fistulectomy 2 2 6 2 1 1 Serous 2 Flatus 2 56 
56 56 11396 31 F Fistulectomy 2 1 1 1 2 2 Nil 1 Nil 1 48 
57 57 28926 58 F Fistulectomy 2 2 8 3 2 2 Serous 2 Flatus 2 54 
58 58 25721 40 M Fistulectomy 2 1 1 1 1 1 Serous 2 Nil 1 48 
59 59 27975 34 M Fistulectomy 2 1 1 1 1 1 Serous 2 Nil 1 42 
60 60 12474 30 M Fistulectomy 2 1 4 2 1 1 Nil 1 Nil 1 52 
 
Key to master chart: 
Procedure code  
 1- fistulotomy 
  2-fistulectomy 
 
Diagnosis 
1-intersphincteric 
2-transsphincteric 
 
Pain score  
1-3  
1- mild  
2-moderate 
3-severe 
 
Bleeding 
1 </=1 pads soaked 
2  - 2-3 pads soaked 
3 - > 3 pads soaked 
 
Infection 
1-nil 
2- serous discharge 
3- purulent discharge 
 
Incontinence 
1-nil 
2- flatus 
3- faeces  
 ABBREVATIONS 
DRE – DIGITAL RECTAL EXAMINATION 
CD  -  CROHN’S DISEASE 
UC -  ULCEARTIVE COLITIS 
CT -  COMPUTED TOMOGRAPHY 
MRI – MAGNETIC RESONANCE IMAGING 
STIR - SHORT-INVERSION-TIME INVERSION RECOVERY 
LIFT –LIGATION OF THE INTERSPHINCTERIC FISTULA TRACT 
VAAFT -VIDEO-ASSISTED ANAL FISTULOUS TREATMENT 
